André P, Komurian-Pradel F, Deforges S, Perret M, Berland J L, Sodoyer M, Pol S, Bréchot C, Paranhos-Baccalà G, Lotteau V
INSERM U503, CERVI, Lyon, France.
J Virol. 2002 Jul;76(14):6919-28. doi: 10.1128/jvi.76.14.6919-6928.2002.
The presence of hepatitis C virus (HCV) RNA-containing particles in the low-density fractions of plasma has been associated with high infectivity. However, the nature of circulating HCV particles and their association with immunoglobulins or lipoproteins as well as the characterization of cell entry have all been subject to conflicting reports. For a better analysis of HCV RNA-containing particles, we quantified HCV RNA in the low-density fractions of plasma corresponding to the very-low-density lipoprotein (VLDL), intermediate-density lipoprotein, and low-density lipoprotein (LDL) fractions from untreated chronically HCV-infected patients. HCV RNA was always found in at least one of these fractions and represented 8 to 95% of the total plasma HCV RNA. Surprisingly, immunoglobulins G and M were also found in the low-density fractions and could be used to purify the HCV RNA-containing particles (lipo-viro-particles [LVP]). Purified LVP were rich in triglycerides; contained at least apolipoprotein B, HCV RNA, and core protein; and appeared as large spherical particles with a diameter of more than 100 nm and with internal structures. Delipidation of these particles resulted in capsid-like structures recognized by anti-HCV core protein antibody. Purified LVP efficiently bind and enter hepatocyte cell lines, while serum or whole-density fractions do not. Binding of these particles was competed out by VLDL and LDL from noninfected donors and was blocked by anti-apolipoprotein B and E antibodies, whereas upregulation of the LDL receptor increased their internalization. These results suggest that the infectivity of LVP is mediated by endogenous proteins rather than by viral components providing a mechanism of escape from the humoral immune response.
血浆低密度组分中存在含丙型肝炎病毒(HCV)RNA的颗粒与高传染性相关。然而,循环HCV颗粒的性质及其与免疫球蛋白或脂蛋白的关联以及细胞进入的特征均存在相互矛盾的报道。为了更好地分析含HCV RNA的颗粒,我们对未经治疗的慢性HCV感染患者血浆中对应于极低密度脂蛋白(VLDL)、中间密度脂蛋白和低密度脂蛋白(LDL)组分的低密度组分中的HCV RNA进行了定量。在这些组分中至少有一组总能检测到HCV RNA,其占血浆总HCV RNA的8%至95%。令人惊讶的是,在低密度组分中还发现了免疫球蛋白G和M,它们可用于纯化含HCV RNA的颗粒(脂质病毒颗粒[LVP])。纯化的LVP富含甘油三酯;至少含有载脂蛋白B、HCV RNA和核心蛋白;呈现为直径超过100 nm且具有内部结构的大球形颗粒。这些颗粒的脱脂导致被抗HCV核心蛋白抗体识别的衣壳样结构。纯化的LVP能有效结合并进入肝细胞系,而血清或全密度组分则不能。这些颗粒的结合可被来自未感染供体的VLDL和LDL竞争取代,并被抗载脂蛋白B和E抗体阻断,而LDL受体的上调则增加了它们的内化。这些结果表明,LVP的传染性是由内源性蛋白质介导的,而不是由病毒成分介导的,这提供了一种逃避体液免疫反应的机制。